Evidence map›Paper›PMID 39825187›Full record

ReviewEuropean journal of pediatrics2025

Periorificial dermatitis in infants and preschoolers - a narrative review.

Anca Chiriac, Anca E Chiriac, Bhushan Madke, Monika Fida, Amit Bharat Shinde, Uwe Wollina

Abstract readReview
PubMed Publisher
In one paragraph

Review in European journal of pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anca ChiriacDepartment of Dermatology, Nicolina Medical Center, Iasi, Romania.ORCID https://orcid.org/0000-0002-0989-4931
Anca E ChiriacDepartment of Biophysics, Discipline of Dermato-Cosmetic Equipment, Products and Techniques, Faculty of Pharmacy, Grigore T. Popa University of Medicine and Pharmacy, Iasi, Romania.ORCID https://orcid.org/0000-0002-1944-5507
Bhushan MadkeDepartment of Dermatology, Venereology and Leprosy, Datta Meghe Institute of Higher Education and Research, Jawaharlal Nehru Medical College, Wardha, India.ORCID https://orcid.org/0000-0003-2704-9165
Monika FidaDepartment of Dermatology, University of Medicine, Tirana, Albania.ORCID https://orcid.org/0000-0001-8026-8995
Amit Bharat ShindeDr. Shinde Skin Hair and Cosmetology Clinic, Ahmednagar, Maharashtra, India.
Uwe WollinaDepartment of Dermatology & Allergology, Städtisches Klinikum Dresden, Academic Teaching Hospital, Dresden, Germany. uwollina@gmail.com.ORCID https://orcid.org/0000-0001-5933-2913

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Periorifical dermatitis (POD) is a papular, chronic inflammatory skin disease commonly seen in women in their 2nd to 4th decade of life. The major differential diagnosis is persistent acne. In children, POD is less common than in adults. In infants and preschoolers POD is rare. We performed a narrative review for POD in children ≤6 years of age. Diagnosis is clinical. The disease presents with monomorphic erythematous papules that usually leave a 1-2 mm Grenz zone around the red lips unaffected. Perinasal skin, nostrils and eyelids can be involved, while extrafacial manifestations are rare. The granulomatous subtype of POD is more common in small children that in adults. The most important differential diagnoses in children include atopic and seborrheic dermatosis, pediatric rosacea, juvenile acne, and cutaneous sarcoidosis. While topical macrolides, azelaic acid, and calcineurin inhibitors are often used in mild cases of adult POD, oral tetracyclines are the treatment of choice in more advanced cases. In infants and preschoolers, tetracycline should be avoided since they can affect the calcification (hardening) of the bones and teeth and lead to permanent discoloration of teeth. There are no randomized controlled trials for POD in this age group available. Topical metronidazole or erythromycin and oral erythromycin are most used. New drugs like JAK inhibitors are on the horizon.

Indexed as

Dermatitis, PerioralChild, PreschoolDiagnosis, DifferentialFemaleHumansInfantDifferential diagnosesGranulomatous periorificial dermatitisInfantsPeriorifical dermatitisPreschoolersTreatment

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.